Woo, Wayne

Immunogenicity and Safety of AS03-adjuvanted H5N1 Influenza Vaccine in Children 6–35 Months of Age: Results From a Phase 2, Randomized, Observer-blind, Multicenter, Dose-ranging Study

Kim, J. H., Drame, M., Puthanakit, T., Chiu, N.-C., Supparatpinyo, K., Huang, L.-M., Chiu, C.-H., Chen, P.-Y., Hwang, K.-P., Danier, J., et al. (2021) · Pediatric Infectious Disease Journal

Influenza Virus Research StudiesBacterial Infections and Vaccines

Cited by 14